154 related articles for article (PubMed ID: 26491887)
1. Quantitative Proteomics Reveals That the Inhibition of Na(+)/K(+)-ATPase Activity Affects S-Phase Progression Leading to a Chromosome Segregation Disorder by Attenuating the Aurora A Function in Hepatocellular Carcinoma Cells.
Xu Z; Wang F; Fan F; Gu Y; Shan N; Meng X; Cheng S; Liu Y; Wang C; Song Y; Xu R
J Proteome Res; 2015 Nov; 14(11):4594-602. PubMed ID: 26491887
[TBL] [Abstract][Full Text] [Related]
2. Cinobufagin Triggers Defects in Spindle Formation and Cap-Dependent Translation in Liver Cancer Cells by Inhibiting the AURKA-mTOR-eIF4E Axis.
Jin X; Wang J; Zou S; Xu R; Cao J; Zhang Y; Guo J; Wen X; Deng S; Zheng Y; Zhu Y; Wang F; Xu Z
Am J Chin Med; 2020; 48(3):651-678. PubMed ID: 32349518
[TBL] [Abstract][Full Text] [Related]
3. Targeting the Na(+)/K(+)-ATPase alpha1 subunit of hepatoma HepG2 cell line to induce apoptosis and cell cycle arresting.
Xu ZW; Wang FM; Gao MJ; Chen XY; Hu WL; Xu RC
Biol Pharm Bull; 2010; 33(5):743-51. PubMed ID: 20460749
[TBL] [Abstract][Full Text] [Related]
4. [Effect of Na(+)/K(+)-ATPase alpha1 siRNA and ouabain upon cell cycle in human hepatoma HepG2 cell and its mechanism].
Xu ZW; Wang FM; Xu RC; Hu WL; Chen XY
Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(12):813-7. PubMed ID: 20450619
[TBL] [Abstract][Full Text] [Related]
5. Combined inhibition of AURKA and HSF1 suppresses proliferation and promotes apoptosis in hepatocellular carcinoma by activating endoplasmic reticulum stress.
Shen Z; Yin L; Zhou H; Ji X; Jiang C; Zhu X; He X
Cell Oncol (Dordr); 2021 Oct; 44(5):1035-1049. PubMed ID: 34176092
[TBL] [Abstract][Full Text] [Related]
6. A MYC-aurora kinase A protein complex represents an actionable drug target in p53-altered liver cancer.
Dauch D; Rudalska R; Cossa G; Nault JC; Kang TW; Wuestefeld T; Hohmeyer A; Imbeaud S; Yevsa T; Hoenicke L; Pantsar T; Bozko P; Malek NP; Longerich T; Laufer S; Poso A; Zucman-Rossi J; Eilers M; Zender L
Nat Med; 2016 Jul; 22(7):744-53. PubMed ID: 27213815
[TBL] [Abstract][Full Text] [Related]
7. SC-III3, a novel scopoletin derivative, induces cytotoxicity in hepatocellular cancer cells through oxidative DNA damage and ataxia telangiectasia-mutated nuclear protein kinase activation.
Zhao P; Chen L; Li LH; Wei ZF; Tong B; Jia YG; Kong LY; Xia YF; Dai Y
BMC Cancer; 2014 Dec; 14():987. PubMed ID: 25527123
[TBL] [Abstract][Full Text] [Related]
8. [The mechanism study of ouabain in inhibiting the growth of hepatocellular carcinoma cells by inhibiting the laser kinase signaling pathway].
Fu LN; Xu ZW; Xu RC; Fang T; Wang FM
Zhonghua Yi Xue Za Zhi; 2020 Oct; 100(38):3014-3017. PubMed ID: 33086454
[No Abstract] [Full Text] [Related]
9. Increase in ouabain-sensitive K+-ATPase activity in hepatocellular carcinoma by overexpression of Na+, K+-ATPase alpha 3-isoform.
Shibuya K; Fukuoka J; Fujii T; Shimoda E; Shimizu T; Sakai H; Tsukada K
Eur J Pharmacol; 2010 Jul; 638(1-3):42-6. PubMed ID: 20447393
[TBL] [Abstract][Full Text] [Related]
10. Na+/K+-ATPase α1 subunit, a novel therapeutic target for hepatocellular carcinoma.
Zhuang L; Xu L; Wang P; Jiang Y; Yong P; Zhang C; Zhang H; Meng Z; Yang P
Oncotarget; 2015 Sep; 6(29):28183-93. PubMed ID: 26334094
[TBL] [Abstract][Full Text] [Related]
11. Water extract of Hedyotis Diffusa Willd suppresses proliferation of human HepG2 cells and potentiates the anticancer efficacy of low-dose 5-fluorouracil by inhibiting the CDK2-E2F1 pathway.
Chen XZ; Cao ZY; Chen TS; Zhang YQ; Liu ZZ; Su YT; Liao LM; Du J
Oncol Rep; 2012 Aug; 28(2):742-8. PubMed ID: 22641337
[TBL] [Abstract][Full Text] [Related]
12. NCPMF-60 induces G2/M cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells.
Dai QS; Liu W; Wang XB; Lu N; Gong DD; Kong LY; Guo QL
Anticancer Drugs; 2011 Jan; 22(1):46-57. PubMed ID: 20948430
[TBL] [Abstract][Full Text] [Related]
13. Cardiotonic steroids attenuate ERK phosphorylation and generate cell cycle arrest to block human hepatoma cell growth.
Xu ZW; Wang FM; Gao MJ; Chen XY; Shan NN; Cheng SX; Mai X; Zala GH; Hu WL; Xu RC
J Steroid Biochem Mol Biol; 2011 Jul; 125(3-5):181-91. PubMed ID: 21215801
[TBL] [Abstract][Full Text] [Related]
14. The lipid homeostasis regulation study of arenobufagin in zebrafish HepG2 xenograft model and HepG2 cells using integrated lipidomics-proteomics approach.
Zhao LJ; Zhao HY; Wei XL; Guo FF; Wei JY; Wang HJ; Yang J; Yang ZG; Si N; Bian BL
J Ethnopharmacol; 2020 Oct; 260():112943. PubMed ID: 32422359
[TBL] [Abstract][Full Text] [Related]
15. AURKA promotes cancer metastasis by regulating epithelial-mesenchymal transition and cancer stem cell properties in hepatocellular carcinoma.
Chen C; Song G; Xiang J; Zhang H; Zhao S; Zhan Y
Biochem Biophys Res Commun; 2017 Apr; 486(2):514-520. PubMed ID: 28322787
[TBL] [Abstract][Full Text] [Related]
16. The anticancer effects of cinobufagin on hepatocellular carcinoma Huh‑7 cells are associated with activation of the p73 signaling pathway.
Zhao L; Fu L; Xu Z; Fan R; Xu R; Fu R; Zou S; Wang C; Zhang Y; Wang J; Bao J; Wang Z; Hou X; Zheng Y; Dai E; Wang F
Mol Med Rep; 2019 May; 19(5):4119-4128. PubMed ID: 30942456
[TBL] [Abstract][Full Text] [Related]
17. p53/mdm2 feedback loop sustains miR-221 expression and dictates the response to anticancer treatments in hepatocellular carcinoma.
Fornari F; Milazzo M; Galassi M; Callegari E; Veronese A; Miyaaki H; Sabbioni S; Mantovani V; Marasco E; Chieco P; Negrini M; Bolondi L; Gramantieri L
Mol Cancer Res; 2014 Feb; 12(2):203-16. PubMed ID: 24324033
[TBL] [Abstract][Full Text] [Related]
18. mTORC1 Up-Regulates GP73 to Promote Proliferation and Migration of Hepatocellular Carcinoma Cells and Growth of Xenograft Tumors in Mice.
Chen X; Wang Y; Tao J; Shi Y; Gai X; Huang F; Ma Q; Zhou Z; Chen H; Zhang H; Liu Z; Sun Q; Peng H; Chen R; Jing Y; Yang H; Mao Y; Zhang H
Gastroenterology; 2015 Sep; 149(3):741-52.e14. PubMed ID: 25980751
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Aurora A Kinase by Alisertib Induces Autophagy and Cell Cycle Arrest and Increases Chemosensitivity in Human Hepatocellular Carcinoma HepG2 Cells.
Zhu Q; Yu X; Zhou ZW; Zhou C; Chen XW; Zhou SF
Curr Cancer Drug Targets; 2017; 17(4):386-401. PubMed ID: 27396604
[TBL] [Abstract][Full Text] [Related]
20. Aurora kinase A mediates c-Myc's oncogenic effects in hepatocellular carcinoma.
Lu L; Han H; Tian Y; Li W; Zhang J; Feng M; Li Y
Mol Carcinog; 2015 Nov; 54(11):1467-79. PubMed ID: 25284017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
